MM, L., APM, C., TM, F., J, K., AC, Y., & FM, C. (2025). Efficacy and safety of dupilumab in the treatment of moderate-to-severe atopic dermatitis: A real-life study. Drugs in context, 14, . https://doi.org/10.7573/dic.2025-3-5
Chicago Style (17th ed.) CitationMM, Lopes, Castro APM, Ferrisse TM, Kalil J, Yang AC, and Castro FM. "Efficacy and Safety of Dupilumab in the Treatment of Moderate-to-severe Atopic Dermatitis: A Real-life Study." Drugs in Context 14 (2025). https://doi.org/10.7573/dic.2025-3-5.
MLA (9th ed.) CitationMM, Lopes, et al. "Efficacy and Safety of Dupilumab in the Treatment of Moderate-to-severe Atopic Dermatitis: A Real-life Study." Drugs in Context, vol. 14, 2025, https://doi.org/10.7573/dic.2025-3-5.
Warning: These citations may not always be 100% accurate.